$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-K Financial Statement

#000101473915000004 Filed on March 02, 2015

Income Statement

Concept	2015 Q1	2013 Q4	2013 Q3
Revenue	$244.4M	$225.5M	$190.6M
YoY Change	2.11%	24.76%	11.9%
Cost Of Revenue	$179.4M	$157.3M	$129.0M
YoY Change	2.99%	96.13%	14.79%
Gross Profit	$64.96M	$68.20M	$61.66M
YoY Change	4.53%	12.92%	6.29%
Gross Profit Margin	26.58%	30.24%	32.34%
Selling, General & Admin	$20.00M	$69.30M	$56.10M
YoY Change	-69.6%	131.0%	11.75%
% of Gross Profit	30.79%	101.62%	90.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.794M	$1.900M	$3.225M
YoY Change	51.04%	58.33%	51.12%
% of Gross Profit	8.92%	2.79%	5.23%
Operating Expenses	$67.50M	$65.80M	$56.60M
YoY Change	3.37%	111.58%	10.33%
Operating Profit	-$6.203M	$2.396M	-$688.0K
YoY Change	-44.94%	-91.82%	-120.32%
Interest Expense	-$9.200M	-$8.000M	$7.183M
YoY Change	-187.63%	25.0%	10.56%
% of Operating Profit		-333.89%
Other Income/Expense, Net
YoY Change
Pretax Income	-$15.37M	-$13.01M	-$23.77M
YoY Change	-34.9%	32.77%	664.03%
Income Tax	$1.928M	$2.600M	-$13.00K
% Of Pretax Income
Net Earnings	-$19.67M	-$18.56M	-$34.09M
YoY Change	-22.28%	-358.48%	195.48%
Net Earnings / Revenue	-8.05%	-8.23%	-17.88%
Basic Earnings Per Share		-$0.27	-$0.53
Diluted Earnings Per Share	-$1.145M	-$1.094M	-$0.53
COMMON SHARES
Basic Shares Outstanding	68.64M shares	68.11M shares	67.91M shares
Diluted Shares Outstanding			67.91M shares

Balance Sheet

Concept	2015 Q1	2013 Q4	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.20M	$1.000M	$0.00
YoY Change	149.46%	-98.39%	-100.0%
Cash & Equivalents	$23.25M	$1.001M	$0.00
Short-Term Investments
Other Short-Term Assets	$10.60M	$29.40M	$13.30M
YoY Change	-13.82%	188.24%	49.44%
Inventory	$41.88M	$34.34M	$30.33M
Prepaid Expenses
Receivables	$136.7M	$172.2M	$178.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$212.4M	$237.0M	$222.1M
YoY Change	-15.51%	0.65%	-12.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$35.93M	$41.18M	$41.05M
YoY Change	-10.06%	73.61%	94.35%
Goodwill	$573.3M	$571.3M	$605.7M
YoY Change	0.26%	80.22%	72.75%
Intangibles		$16.82M	$34.09M
YoY Change		-3.57%	96.27%
Long-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$1.247M	$3.733M	$4.487M
YoY Change	-65.13%	81.83%	108.6%
Total Long-Term Assets	$633.1M	$699.9M	$704.2M
YoY Change	-2.41%	71.99%	75.15%
TOTAL ASSETS
Total Short-Term Assets	$212.4M	$237.0M	$222.1M
Total Long-Term Assets	$633.1M	$699.9M	$704.2M
Total Assets	$845.4M	$936.9M	$926.3M
YoY Change	-6.07%	45.84%	41.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$91.11M	$63.58M	$50.28M
YoY Change	33.42%	84.61%	4.38%
Accrued Expenses	$43.70M	$38.50M	$38.00M
YoY Change	-2.89%	-18.6%	-22.45%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$300.0K	$60.26M	$35.30M
YoY Change	-25.0%	6222.88%	3430.0%
Total Short-Term Liabilities	$145.2M	$176.3M	$133.5M
YoY Change	13.79%	62.86%	2.25%
LONG-TERM LIABILITIES
Long-Term Debt	$418.5M	$375.3M	$380.3M
YoY Change	0.07%	66.49%	68.65%
Other Long-Term Liabilities	$2.656M	$17.54M	$30.40M
YoY Change	-70.29%	252.14%	399.7%
Total Long-Term Liabilities	$2.656M	$392.9M	$30.40M
YoY Change	-70.29%	70.51%	399.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$145.2M	$176.3M	$133.5M
Total Long-Term Liabilities	$2.656M	$392.9M	$30.40M
Total Liabilities	$587.2M	$582.3M	$556.0M
YoY Change	3.49%	66.86%	48.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$321.9M	-$154.7M	-$136.2M
YoY Change	78.77%	81.86%	47.6%
Common Stock	$536.8M	$519.6M	$516.8M
YoY Change	2.64%	33.65%	33.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.72M	$10.31M	$10.31M
YoY Change	3.92%	0.0%	0.0%
Treasury Stock Shares	2.645M shares	2.583M shares	2.583M shares
Shareholders Equity	$204.2M	$354.6M	$370.3M
YoY Change
Total Liabilities & Shareholders Equity	$845.4M	$936.9M	$926.3M
YoY Change	-6.07%	45.84%	41.03%

Cashflow Statement

Concept	2015 Q1	2013 Q4	2013 Q3
OPERATING ACTIVITIES
Net Income	-$19.67M	-$18.56M	-$34.09M
YoY Change	-22.28%	-358.48%	195.48%
Depreciation, Depletion And Amortization	$5.794M	$1.900M	$3.225M
YoY Change	51.04%	58.33%	51.12%
Cash From Operating Activities	-$28.05M	-$16.30M	-$16.20M
YoY Change	7.93%	-1118.75%	-537.84%
INVESTING ACTIVITIES
Capital Expenditures	-$2.100M	-$5.600M	-$8.900M
YoY Change	-32.26%	7.69%	323.81%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$2.100M	-$212.3M
YoY Change	-100.0%	-151.22%	405.48%
Cash From Investing Activities	-$2.066M	-$3.600M	-$221.3M
YoY Change	-103.86%	-61.29%	401.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$52.62M	20.80M	155.9M
YoY Change	-372.38%	700.0%	-606.17%
NET CHANGE
Cash From Operating Activities	-$28.05M	-16.30M	-16.20M
Cash From Investing Activities	-$2.066M	-3.600M	-221.3M
Cash From Financing Activities	$52.62M	20.80M	155.9M
Net Change In Cash	$22.51M	900.0K	-81.60M
YoY Change	172.73%	-117.65%	14.61%
FREE CASH FLOW
Cash From Operating Activities	-$28.05M	-$16.30M	-$16.20M
Capital Expenditures	-$2.100M	-$5.600M	-$8.900M
Free Cash Flow	-$25.95M	-$10.70M	-$7.300M
YoY Change	13.37%	-257.35%	-225.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	36371000	USD
CY2014Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	46092000	USD
CY2012	bios	Acquisition And Integration Expenses AcquisitionAndIntegrationExpenses	4046000	USD
CY2013	bios	Acquisition And Integration Expenses AcquisitionAndIntegrationExpenses	16130000	USD
CY2014	bios	Acquisition And Integration Expenses AcquisitionAndIntegrationExpenses	17924000	USD
CY2012	bios	Adjusted Ebitda AdjustedEbitda	61065000	USD
CY2013	bios	Adjusted Ebitda AdjustedEbitda	77780000	USD
CY2014	bios	Adjusted Ebitda AdjustedEbitda	13232000	USD
CY2013Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	4826000	USD
CY2014Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	5779000	USD
CY2014	bios	Available Shares Reduced Per Restricted Stock Share Issued AvailableSharesReducedPerRestrictedStockShareIssued	1.53	shares
CY2012	bios	Cash Consideration Paid To Ds Pharmacy CashConsiderationPaidToDsPharmacy	2935000	USD
CY2013	bios	Cash Consideration Paid To Ds Pharmacy CashConsiderationPaidToDsPharmacy	0	USD
CY2014	bios	Cash Consideration Paid To Ds Pharmacy CashConsiderationPaidToDsPharmacy	0	USD
CY2014	bios	Cash Equivalents Maturity Term Maximum CashEquivalentsMaturityTermMaximum	P3M
CY2010Q1	bios	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	3400000	shares
CY2010Q1	bios	Class Of Warrant Or Right Term ClassOfWarrantOrRightTerm	P5Y
CY2013	bios	Debt Instrument Redemption Premium DebtInstrumentRedemptionPremium	12162000	USD
CY2014	bios	Debt Instrument Redemption Premium DebtInstrumentRedemptionPremium	0	USD
CY2012	bios	Disposal Group Including Discontinued Operation Interest Income Expense DisposalGroupIncludingDiscontinuedOperationInterestIncomeExpense	761000	USD
CY2013	bios	Disposal Group Including Discontinued Operation Interest Income Expense DisposalGroupIncludingDiscontinuedOperationInterestIncomeExpense	-41000	USD
CY2014	bios	Disposal Group Including Discontinued Operation Interest Income Expense DisposalGroupIncludingDiscontinuedOperationInterestIncomeExpense	0	USD
CY2014Q4	bios	Future Minimum Leases Due Thereafter FutureMinimumLeasesDueThereafter	2333000	USD
CY2014Q4	bios	Future Minimum Payments Due FutureMinimumPaymentsDue	31927000	USD
CY2014Q4	bios	Future Minimum Payments Due Current FutureMinimumPaymentsDueCurrent	9008000	USD
CY2014Q4	bios	Future Minimum Payments Due In Five Years FutureMinimumPaymentsDueInFiveYears	2634000	USD
CY2014Q4	bios	Future Minimum Payments Due In Four Years FutureMinimumPaymentsDueInFourYears	4320000	USD
CY2014Q4	bios	Future Minimum Payments Due In Three Years FutureMinimumPaymentsDueInThreeYears	6267000	USD
CY2014Q4	bios	Future Minimum Payments Due In Two Years FutureMinimumPaymentsDueInTwoYears	7365000	USD
CY2012	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	0	USD
CY2013	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	5786000	USD
CY2014	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	7364000	USD
CY2014Q4	bios	Income Tax Expense Benefit Related To Prior Years IncomeTaxExpenseBenefitRelatedToPriorYears	1100000	USD
CY2012	bios	Increase Decreasein Amountsduetoplansponsor IncreaseDecreaseinAmountsduetoplansponsor	-7025000	USD
CY2013	bios	Increase Decreasein Amountsduetoplansponsor IncreaseDecreaseinAmountsduetoplansponsor	-13105000	USD
CY2014	bios	Increase Decreasein Amountsduetoplansponsor IncreaseDecreaseinAmountsduetoplansponsor	953000	USD
CY2012	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	0	USD
CY2013	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	5786000	USD
CY2014	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	7364000	USD
CY2013	bios	Legal Feesand Other Expenseson Extinguishmentof Debt LegalFeesandOtherExpensesonExtinguishmentofDebt	235000	USD
CY2014	bios	Legal Feesand Other Expenseson Extinguishmentof Debt LegalFeesandOtherExpensesonExtinguishmentofDebt	0	USD
CY2013Q4	bios	Long Term Debt And Capital Lease Obligations Total LongTermDebtAndCapitalLeaseObligationsTotal	435579000	USD
CY2014Q4	bios	Long Term Debt And Capital Lease Obligations Total LongTermDebtAndCapitalLeaseObligationsTotal	423803000	USD
CY2014	bios	Number Of Large Markets NumberOfLargeMarkets	7	Market
CY2014	bios	Number Of Legacy Billing Systems NumberOfLegacyBillingSystems	5	System
CY2014Q4	bios	Number Of Stock Based Compensation Plans NumberOfStockBasedCompensationPlans	2	stock_compensation_plan
CY2014	bios	Number Of Types Of Accounts Receivable NumberOfTypesOfAccountsReceivable	3	accounts_receivable
CY2012	bios	Other Interest Income Expense Net OtherInterestIncomeExpenseNet	170000	USD
CY2013	bios	Other Interest Income Expense Net OtherInterestIncomeExpenseNet	13000	USD
CY2014	bios	Other Interest Income Expense Net OtherInterestIncomeExpenseNet	189000	USD
CY2010Q1	bios	Percentageof Fair Valueof Common Stock Issuedthatwill Trigger Increasein Common Stock Issued Upon Exerciseof Warrants PercentageofFairValueofCommonStockIssuedthatwillTriggerIncreaseinCommonStockIssuedUponExerciseofWarrants	0.9
CY2013Q2	bios	Proceedsfrom Issuanceof Common Stock Used To Fund Acquisition ProceedsfromIssuanceofCommonStockUsedToFundAcquisition	61100000	USD
CY2012	bios	Restructuring Charges Other Expensesand Investments RestructuringChargesOtherExpensesandInvestments	5142000	USD
CY2013	bios	Restructuring Charges Other Expensesand Investments RestructuringChargesOtherExpensesandInvestments	10478000	USD
CY2014	bios	Restructuring Charges Other Expensesand Investments RestructuringChargesOtherExpensesandInvestments	18610000	USD
CY2013Q2	bios	Stock Issued During Period Shares Selling Stockholders StockIssuedDuringPeriodSharesSellingStockholders	3968750	shares
CY2012	bios	Stock Issued During Period Value Treasury Stock Reissued Compensation StockIssuedDuringPeriodValueTreasuryStockReissuedCompensation	0	USD
CY2012	bios	Surrender Of Stock To Satisfy Minimum Tax Withholding SurrenderOfStockToSatisfyMinimumTaxWithholding	174000	USD
CY2013	bios	Surrender Of Stock To Satisfy Minimum Tax Withholding SurrenderOfStockToSatisfyMinimumTaxWithholding	0	USD
CY2014	bios	Surrender Of Stock To Satisfy Minimum Tax Withholding SurrenderOfStockToSatisfyMinimumTaxWithholding	368000	USD
CY2012	bios	Transitional Expense State Tax Related TransitionalExpenseStateTaxRelated	800000	USD
CY2012	bios	Transitional Expenses TransitionalExpenses	3000000	USD
CY2013	bios	Transitional Expenses TransitionalExpenses	4400000	USD
CY2014	bios	Transitional Expenses TransitionalExpenses	4400000	USD
CY2014	bios	Warrants Exercised WarrantsExercised	0	shares
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-12-31
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	68636965	shares
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q2	dei	Entity Public Float EntityPublicFloat	566219922	USD
CY2014	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	63575000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	90032000	USD
CY2013Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	190024000	USD
CY2014Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	207310000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42016000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50643000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	519625000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	529682000	USD
CY2012	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	174000	USD
CY2014	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	368000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4986000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9498000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8590000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	17836000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	66500000	USD
CY2012	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2013	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2014	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	462000	USD
CY2012	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1261000	USD
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2259000	USD
CY2012Q4	us-gaap	Assets Assets	642376000	USD
CY2013Q4	us-gaap	Assets Assets	936858000	USD
CY2014Q4	us-gaap	Assets Assets	824713000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	236956000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	188215000	USD
CY2013Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	15316000	USD
CY2013	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-101000	USD
CY2014	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	57688000	USD
CY2012	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-22457000	USD
CY2013	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-8542000	USD
CY2014	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-6771000	USD
CY2010Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.00
CY2014	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3691000	USD
CY2012	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1261000	USD
CY2013	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2259000	USD
CY2014	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4153000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3957000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6671000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6555000	USD
CY2014Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2012	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	6631000	USD
CY2013	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	20000	USD
CY2014	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	107000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	614000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	418000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	12000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	62000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	122000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2012	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	1300000	USD
CY2013	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	1700000	USD
CY2014	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	2400000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62101000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1001000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	740000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	62101000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-61100000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-261000	USD
CY2012	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	161171000	USD
CY2014Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3100000	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-129000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	377000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	13463000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-32000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4801000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12318000	USD
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70711439	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71274064	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68128919	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68636965	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	7000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2012	us-gaap	Cost Of Revenue CostOfRevenue	397545000	USD
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	525845000	USD
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	722989000	USD
CY2012	us-gaap	Cost Of Services CostOfServices	72274000	USD
CY2013	us-gaap	Cost Of Services CostOfServices	59690000	USD
CY2014	us-gaap	Cost Of Services CostOfServices	77570000	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-6095000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-866000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-886000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-7085000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-2278000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-927000	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-990000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-1412000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-41000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	97000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4424000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	9951000	USD
CY2013Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	17184000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2367000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	7556000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	8499000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	63300000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	111170000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	39265000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	65097000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	417000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	610000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	301000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6277000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8201000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.57
CY2014Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.92
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	38000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	9785000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	28424000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	61110000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	111170000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8954000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	21272000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	2019000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	2214000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	679000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	0	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	9969000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	21272000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	6935000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	19058000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	496000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2013	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	500000	USD
CY2014	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1600000	USD
CY2014	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2012	us-gaap	Depreciation Depreciation	8367000	USD
CY2013	us-gaap	Depreciation Depreciation	13381000	USD
CY2014	us-gaap	Depreciation Depreciation	16388000	USD
CY2013Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	49642000	USD
CY2014Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	1.15
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.53
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.08
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.37
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.29
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.15
CY2014Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	9300000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16526000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	23081000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	0	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5142000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	0	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	66000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1983000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3078000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	33350000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	33350000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16824000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10269000	USD
CY2012	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-156000	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2012	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-15898000	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2373000	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26755000	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32042000	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36264000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	317026000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	571337000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	573323000	USD
CY2013	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	254304000	USD
CY2014	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2013	us-gaap	Goodwill Other Changes GoodwillOtherChanges	7000	USD
CY2014	us-gaap	Goodwill Other Changes GoodwillOtherChanges	1986000	USD
CY2012	us-gaap	Gross Profit GrossProfit	195902000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	55987000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	57775000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	61655000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	68196000	USD
CY2013	us-gaap	Gross Profit GrossProfit	243613000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	65100000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	65356000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	65002000	USD
CY2014Q4	us-gaap	Gross Profit GrossProfit	65608000	USD
CY2014	us-gaap	Gross Profit GrossProfit	261066000	USD
CY2012	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	325271000	USD
CY2013	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	466155000	USD
CY2014	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	645419000	USD
CY2012	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	471506000	USD
CY2013	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	675684000	USD
CY2014	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	901653000	USD
CY2012	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	121941000	USD
CY2013	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	93774000	USD
CY2014	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	82402000	USD
CY2012	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	593447000	USD
CY2013Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	181020000	USD
CY2013Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	172323000	USD
CY2013Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	190631000	USD
CY2013Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	225484000	USD
CY2013	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	769458000	USD
CY2014Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	239293000	USD
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2014Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.02
CY2014Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	247125000	USD
CY2014Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	243959000	USD
CY2014Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	253678000	USD
CY2014	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	984055000	USD
CY2013	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-12275000	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-56991000	USD
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-143382000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-19392000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8538000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9150000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-23769000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-13011000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-54468000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-21765000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-15548000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-35645000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-59033000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-131991000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.22
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.15
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.14
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.37
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.23
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.89
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.37
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.27
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.55
CY2014Q4	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.90
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-2.09
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	76982000	USD
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	235000	USD
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	416000	USD
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-10331000	USD
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2983000	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-12663000	USD
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-58000	USD
CY2014Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1207000	USD
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1135000	USD
CY2014Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1686000	USD
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-4086000	USD
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	1.37
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.01
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.16
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.04
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.19
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7117000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2523000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	26021000	USD
CY2012	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	32000	USD
CY2013	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-4801000	USD
CY2014	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-12318000	USD
CY2012	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-4354000	USD
CY2013	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-4864000	USD
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.02
CY2014Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.02
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.06
CY2012	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-675000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11391000	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1077000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	23762000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	61227000	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6788000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-18107000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-46197000	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	0	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	317000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	0	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	128000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	167000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	174000	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-901000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2459000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3704000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-633000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-1157000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-109000	USD
CY2012	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1042000	USD
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3137000	USD
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1651000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-48369000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	22260000	USD
CY2014	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	5614000	USD
CY2012	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-22000	USD
CY2013	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-3627000	USD
CY2014	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	4681000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15249000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4939000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2952000	USD
CY2012	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	9062000	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	375322000	USD
CY2014Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	418408000	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	60257000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	824713000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	176325000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	162313000	USD
CY2013Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	6576000	USD
CY2014Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2013Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	6153000	USD
CY2014Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	USD
CY2013	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0543
CY2013	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-8005000	USD
CY2014	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	5313000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3805000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	456000	USD
CY2014	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0855
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	422757000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5464000	USD
CY2013	us-gaap	Interest Paid Net InterestPaidNet	25589000	USD
CY2014	us-gaap	Interest Paid Net InterestPaidNet	34133000	USD
CY2013Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2173000	USD
CY2012	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-103937000	USD
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	33511000	USD
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-30650000	USD
CY2012	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-26068000	USD
CY2013	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-28198000	USD
CY2014	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-38539000	USD
CY2012	us-gaap	Interest Paid Net InterestPaidNet	27528000	USD
CY2014Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6853000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	34341000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	37215000	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	6200000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	7900000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	7600000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	582275000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	607908000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	936858000	USD
CY2014Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	5395000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	60257000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5395000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	422757000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-58663000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	295823000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13102000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	93880000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-302370000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	44257000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-67291000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-302269000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-13431000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26884000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54553000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31416000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	49341000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-46011000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-24645000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	64707000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-8128000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-8880000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-34087000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-18559000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-69654000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-25314000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-19818000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-38710000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-63626000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-147468000	USD
CY2014	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2014	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	6676000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-10372000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-91079000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	31313000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	8590000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2634000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4308000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	6205000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7243000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	2333000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3733000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1272000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17540000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8129000	USD
CY2012	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	162879000	USD
CY2013	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	209627000	USD
CY2014	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	239810000	USD
CY2012	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	0	USD
CY2013	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	2363000	USD
CY2014	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	0	USD
CY2012	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	10658000	USD
CY2013	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	25525000	USD
CY2014	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	13829000	USD
CY2012	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2013	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2014	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1135000	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	43046000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	282998000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	454000	USD
CY2012	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	10652000	USD
CY2013	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2014	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14110000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9450000	USD
CY2013Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	118400000	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	118382000	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	194539000	USD
CY2012	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1244050000	USD
CY2013	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	449559000	USD
CY2014	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	244700000	USD
CY2012	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2013	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	378091000	USD
CY2014	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2012	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2013	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	8617000	USD
CY2014	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	852000	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8611000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2549000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1468000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	83198000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	88814000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41182000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38171000	USD
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13201000	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	19625000	USD
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	79574000	USD
CY2014Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	47400000	USD
CY2013Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	172188000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	140810000	USD
CY2013Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	21000000	USD
CY2012	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1307872000	USD
CY2013	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	409559000	USD
CY2014	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	279703000	USD
CY2012	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	3278000	USD
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	802000	USD
CY2014	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	360000	USD
CY2012	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2013	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	5000000	USD
CY2014	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	172243000	USD
CY2012	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
CY2013	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	237397000	USD
CY2014	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
CY2012	us-gaap	Restructuring Charges RestructuringCharges	5143000	USD
CY2013	us-gaap	Restructuring Charges RestructuringCharges	7718000	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	15646000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-154738000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-302206000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	6122000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	9450000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	8570000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1900000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2500000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4400000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3800000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	600000	USD
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	3523697	shares
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	6837006	shares
CY2013Q2	us-gaap	Share Price SharePrice	12
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	6.69
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	7.65
CY2014	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y4M26D
CY2012	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	25999	shares
CY2014	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	54579	shares
CY2013	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	399000	USD
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	10406250	shares
CY2013	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	0	shares
CY2014	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	0	shares
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	118382000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8611000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2549000	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1468000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	215279000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	293409000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	354583000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	216805000	USD
CY2013Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	2547000	USD
CY2014Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	8162000	USD
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2582520	shares
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2637099	shares
CY2013	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10311000	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10679000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2605000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2754000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1172000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1096000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	636000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	100000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	100000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	487000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1582000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	76000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	100000	USD
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56239000	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	64560000	shares
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68476000	shares
CY2013	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	3501000	USD
CY2014Q4	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	2373000	USD
CY2014	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	2373000	USD
CY2014	us-gaap	Revenue Recognition Rebates RevenueRecognitionRebates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rebates</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturers’ rebates are part of each of the Company’s segments.  Rebates are generally volume-based incentives that are earned and recorded upon purchase of the inventory.  Rebates are recorded as a reduction of both inventory and cost of goods sold.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PBM rebates are recorded on historical PBM results and trends and are revised on a regular basis depending on the Company’s latest forecasts, as well as information received from rebate sources.  Should actual results differ, adjustments will be recorded in future earnings when the adjustment becomes known.  In some instances, rebate payments are shared with the Company’s Plan Sponsors.  PBM rebates earned by the Company are recorded as a reduction of cost of goods sold.  PBM rebates shared with clients are recorded as a reduction of revenue consistent with the sales incentive provisions of ASC 605.</font></div></div>
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001014739-15-000004-index-headers.html	Edgar Link	pending
0001014739-15-000004-index.html	Edgar Link	pending
0001014739-15-000004.txt	Edgar Link	pending
0001014739-15-000004-xbrl.zip	Edgar Link	pending
bios-20141231.xml	Edgar Link	completed
bios-20141231.xsd	Edgar Link	pending
bios-20141231x10k.htm	Edgar Link	pending
bios-20141231_cal.xml	Edgar Link	unprocessable
bios-20141231_def.xml	Edgar Link	unprocessable
bios-20141231_lab.xml	Edgar Link	unprocessable
bios-20141231_pre.xml	Edgar Link	unprocessable
bios-201412_chartx47455.jpg	Edgar Link	pending
bios-ex1017xx201412x31x10xk.htm	Edgar Link	pending
bios-ex107xx201412x31x10k.htm	Edgar Link	pending
bios-ex12xx20141231x10k.htm	Edgar Link	pending
bios-ex211xx20141231x10k.htm	Edgar Link	pending
bios-ex231xx20141231x10k.htm	Edgar Link	pending
bios-ex232xx20141231x10k.htm	Edgar Link	pending
bios-ex311xx20141231x10k.htm	Edgar Link	pending
bios-ex312xx20141231x10k.htm	Edgar Link	pending
bios-ex321xx20141231x10k.htm	Edgar Link	pending
bios-ex322xx201412x31x10k.htm	Edgar Link	pending
bioscriplogoa05.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2015 Q1 Form 10-K Financial Statement

#000101473915000004 Filed on March 02, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2015 Q1 Form 10-K Financial Statement

#000101473915000004 Filed on March 02, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch